178 related articles for article (PubMed ID: 32838475)
1. Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study.
Outzen M; Tjønneland A; Hughes DJ; Jenab M; Frederiksen K; Schomburg L; Morris S; Overvad K; Olsen A
Int J Cancer; 2021 Feb; 148(4):876-883. PubMed ID: 32838475
[TBL] [Abstract][Full Text] [Related]
2. Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer.
Ekoue DN; Ansong E; Liu L; Macias V; Deaton R; Lacher C; Picklo M; Nonn L; Gann PH; Kajdacsy-Balla A; Prins GS; Freeman VL; Diamond AM
Prostate; 2018 Mar; 78(4):279-288. PubMed ID: 29314169
[TBL] [Abstract][Full Text] [Related]
3. Interaction of NKX3.1 and SELENOP genotype with prostate cancer recurrence.
Donadio JLS; Liu L; Freeman VL; Ekoue DN; Diamond AM; Bermano G
Prostate; 2019 Apr; 79(5):462-467. PubMed ID: 30582190
[TBL] [Abstract][Full Text] [Related]
4. Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer.
Geybels MS; van den Brandt PA; Schouten LJ; van Schooten FJ; van Breda SG; Rayman MP; Green FR; Verhage BA
J Natl Cancer Inst; 2014 Mar; 106(3):dju003. PubMed ID: 24563517
[TBL] [Abstract][Full Text] [Related]
5. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
Méplan C; Rohrmann S; Steinbrecher A; Schomburg L; Jansen E; Linseisen J; Hesketh J
PLoS One; 2012; 7(11):e48709. PubMed ID: 23133653
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
[TBL] [Abstract][Full Text] [Related]
8. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Cooper ML; Adami HO; Grönberg H; Wiklund F; Green FR; Rayman MP
Cancer Res; 2008 Dec; 68(24):10171-7. PubMed ID: 19074884
[TBL] [Abstract][Full Text] [Related]
9. Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study.
Hughes DJ; Schomburg L; Jenab M; Biessy C; Méplan C; Moskal A; Sun Q; Demircan K; Fedirko V; Weiderpass E; Mukhtar M; Olsen A; Tjønneland A; Overvad K; Schulze M; Nøst TH; Skeie G; Olsen KS; Ricceri F; Grioni S; Palli D; Masala G; Tumino R; Pasanisi F; Amiano P; Colorado Yohar SM; Agudo A; Sánchez MJ; Ardanaz E; Sund M; Andersson A; Perez-Cornago A; Travis R; Heath AK; Dossus L
Free Radic Biol Med; 2023 Nov; 209(Pt 2):381-393. PubMed ID: 37923090
[TBL] [Abstract][Full Text] [Related]
10. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in selenoprotein genes modulate biomarkers of selenium status in response to Brazil nut supplementation (the SU.BRA.NUT study).
Donadio JLS; Rogero MM; Guerra-Shinohara EM; Barbosa F; Desmarchelier C; Borel P; Sneddon AA; Hesketh JE; Cozzolino SMF
Clin Nutr; 2019 Apr; 38(2):539-548. PubMed ID: 29609868
[TBL] [Abstract][Full Text] [Related]
12. Selenium status and risk of prostate cancer in a Danish population.
Outzen M; Tjønneland A; Larsen EH; Friis S; Larsen SB; Christensen J; Overvad K; Olsen A
Br J Nutr; 2016 May; 115(9):1669-77. PubMed ID: 26971676
[TBL] [Abstract][Full Text] [Related]
13. Association of Selenoprotein and Selenium Pathway Genotypes with Risk of Colorectal Cancer and Interaction with Selenium Status.
Fedirko V; Jenab M; Méplan C; Jones JS; Zhu W; Schomburg L; Siddiq A; Hybsier S; Overvad K; Tjønneland A; Omichessan H; Perduca V; Boutron-Ruault MC; Kühn T; Katzke V; Aleksandrova K; Trichopoulou A; Karakatsani A; Kotanidou A; Tumino R; Panico S; Masala G; Agnoli C; Naccarati A; Bueno-de-Mesquita B; Vermeulen RCH; Weiderpass E; Skeie G; Nøst TH; Lujan-Barroso L; Quirós JR; Huerta JM; Rodríguez-Barranco M; Barricarte A; Gylling B; Harlid S; Bradbury KE; Wareham N; Khaw KT; Gunter M; Murphy N; Freisling H; Tsilidis K; Aune D; Riboli E; Hesketh JE; Hughes DJ
Nutrients; 2019 Apr; 11(4):. PubMed ID: 31027226
[TBL] [Abstract][Full Text] [Related]
14. Sex-specific and inter-individual differences in biomarkers of selenium status identified by a calibrated ELISA for selenoprotein P.
Hybsier S; Schulz T; Wu Z; Demuth I; Minich WB; Renko K; Rijntjes E; Köhrle J; Strasburger CJ; Steinhagen-Thiessen E; Schomburg L
Redox Biol; 2017 Apr; 11():403-414. PubMed ID: 28064116
[TBL] [Abstract][Full Text] [Related]
15. Plasma selenoprotein P concentration and lung cancer risk: results from a case-control study nested within the Shanghai Men's Health Study.
Takata Y; Xiang YB; Burk RF; Li H; Hill KE; Cai H; Gao J; Zheng W; Shu XO; Cai Q
Carcinogenesis; 2018 Dec; 39(11):1352-1358. PubMed ID: 30084959
[TBL] [Abstract][Full Text] [Related]
16. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men.
Steinbrecher A; Méplan C; Hesketh J; Schomburg L; Endermann T; Jansen E; Akesson B; Rohrmann S; Linseisen J
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2958-68. PubMed ID: 20852007
[TBL] [Abstract][Full Text] [Related]
17. Diverse Associations of Plasma Selenium Concentrations and SELENOP Gene Polymorphism with Metabolic Syndrome and Its Components.
Zhou L; Luo C; Yin J; Zhu Y; Li P; Chen S; Sun T; Xie M; Shan Z; Cao B; Hu X; Rong Y; Yang W; Li X; Tan A; Liu L
Oxid Med Cell Longev; 2020; 2020():5343014. PubMed ID: 32377302
[TBL] [Abstract][Full Text] [Related]
18. Expression of Selenoprotein Genes and Association with Selenium Status in Colorectal Adenoma and Colorectal Cancer.
Hughes DJ; Kunická T; Schomburg L; Liška V; Swan N; Souček P
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30469315
[TBL] [Abstract][Full Text] [Related]
19. Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite.
Brodin O; Hackler J; Misra S; Wendt S; Sun Q; Laaf E; Stoppe C; Björnstedt M; Schomburg L
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32290626
[TBL] [Abstract][Full Text] [Related]
20. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
Penney KL; Schumacher FR; Li H; Kraft P; Morris JS; Kurth T; Mucci LA; Hunter DJ; Kantoff PW; Stampfer MJ; Ma J
Cancer Prev Res (Phila); 2010 May; 3(5):604-10. PubMed ID: 20424130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
